Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1994-8-11
pubmed:abstractText
MICs of six extended-spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime, FK 037, cefpirome, cefepime), three carbapenems (imipenem, meropenem, biapenem), and vancomycin for 49 penicillin-susceptible (S), 77 penicillin intermediate-resistant (I), and 51 penicillin-resistant (R) pneumococci were determined by agar dilution. Compared with ceftazidime (MICs for 90% of strains tested [MIC90s] of 2.0, 16.0, and 16.0 micrograms/ml for S, I, and R strains, respectively), all other cephalosporins yielded lower MICs (MIC90s of 0.06 to 0.125, 0.5 to 1.0, and 1.0 to 2.0 micrograms/ml against S, I, and R strains, respectively). All three carbapenems were very active, with MIC90s, even for R strains, of < or = 1.0 micrograms/ml. All strains were susceptible to vancomycin (MIC90 of 0.5 micrograms/ml).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1346668, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1452492, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1503454, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1510436, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1523079, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1608677, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1617051, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1617076, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1617079, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1636657, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1749702, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-1810180, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-2203313, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-2808218, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-3364443, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-3838637, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-3885849, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-3893316, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-6555189, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-6593000, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-6611135, http://linkedlifedata.com/resource/pubmed/commentcorrection/8031069-8452361
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
898-900
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.
pubmed:affiliation
Department of Pathology (Clinical Microbiology), Hershey Medical Center, Pennsylvania 17033.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't